AdvancedDx Biological Laboratories USA Inc. Enhances Logistics and Storage Capabilities for Third-Party Clinical Trials in the United States

Newburyport (MA, USA) – Today, AdvancedDx Biological Laboratories USA Inc., a subsidiary of ABL Diagnostics S.A. (FR001400AHX6 – ABLD), a Euronext-listed company specializing in molecular biology assays and software for microbiology laboratories, announced the signing of a new agreement with VELA Diagnostics USA Inc. to expand their services.

This new agreement will benefit ABLD’s sister company, CDL Pharma (, a clinical research organization (CRO) that manages biological samples in clinical research and provides central laboratory services for pharmaceutical laboratories, biotech companies, CROs, and biomedical research companies. CDL Pharma primarily operates as a “B2B type CRO.”

Through the use of a temperature-controlled warehouse in New Jersey, CDL Pharma, in collaboration with ABLD, will now offer dedicated logistics, biobanking, and storage services to their customers conducting clinical trials in the USA.

The execution of a new Logistics and Warehousing Agreement between AdvancedDx Biological Laboratories USA Inc. and VELA Diagnostics USA Inc. strengthens ABLD’s logistics capacity in the USA. The addition of a new biobank facility on the East Coast, with high-level logistics services specialized in biological sample storage and transport compliant with Good Clinical Practices (GCP) and Good Distribution Practices (GDP), will benefit ABLD’s growing Clinical Trials support business activity in the USA.

Dr. Chalom Sayada, CEO of the ABL Group which leads ABL Diagnostics, AdvancedDx Biological Laboratories USA, and CDL Pharma, stated, “The execution of this new agreement will further solidify and streamline our clinical trials support services in the USA. We are committed to providing our clients with high-quality standards for biological sample management, storage, and monitoring.”

Sam Dajani, Chairman & Chief Executive Officer at Vela Operations Singapore Pte. Ltd., said, “This additional Logistics and Warehousing Agreement strengthens the partnership initiated between ABL Diagnostics and us for the US territory. It will enable both groups to work together to support various B2B customers conducting clinical trials in the country.”


ABL DIAGNOSTICS is a worldwide leading international company that offers innovative and proprietary molecular biology assays for genotyping through DNA sequencing – DeepChek®. ABL Diagnostics is listed on compartment B of Euronext’s regulated market in Paris (Euronext: ABLD – ISIN: FR001400AHX6). These molecular biology products generate recurring revenues and cover one of the largest portfolios of microbiology applications. ABL Diagnostics distributes its products globally through its own sales team and a network of exclusive distributors. Their clients include academic laboratories, private laboratories, and researchers seeking robust and innovative microbiology solutions. It is the responsibility of the individual to inquire about the registration status of ABL’s products to comply with local regulations. Only Research Use Only (RUO) tests are available for sale in the USA as listed on the FDA website. For more information, please visit or


Vela Diagnostics is a leading provider of integrated IVD system solutions, from sample to result. Their test solutions utilize the automated Sentosa platform, allowing for NGS and PCR testing in infectious disease and oncology. © 2023 Vela Diagnostics Holding Pte Ltd. All rights reserved. Sentosa® is a registered trademark of Vela Diagnostics Holding Pte Ltd outside Singapore in several markets including the US, EU, PRC, and the UK. All Sentosa products listed above are by Vela Diagnostics.


CDL Pharma is an affiliate of Advanced Biological Laboratories (ABL). This French-based company is a CRO (Contract Research Organization) that offers comprehensive biological sample management solutions in clinical research. CDL Pharma, established in 2005, has extensive experience in centralized biology. CDL Pharma is ISO 9001 V2015 certified for all its activities and adheres to internationally recognized standards (GCP, GCLP…). For more information, please visit


ABL Diagnostics / CDL Pharma

Chalom Sayada

General Manager

Tel.: +33 7 83 64 68 50

Vela Diagnostics

Lucia Vira


This press release contains implicitly or explicitly certain forward-looking statements concerning ABL Diagnostics and its business. These statements are based on assumptions that ABL Diagnostics considers reasonable. However, there is no guarantee that these statements will

Share this article
Shareable URL
Prev Post

Cumbrian initiatives receive £400,000 in funding for ‘levelling up’ efforts

Next Post

INTO University Partnerships’ Foundation Medicine Programme Celebrates Stellar Success

Read next